09777 what network 。

Not Purdy: 49ers hit Green Bay with backup QB, no BosaB.C. premier says feds and provinces plan right-left approach to Trump's tariff plans

Mutual of America Capital Management LLC cut its stake in shares of Pediatrix Medical Group, Inc. ( NYSE:MD – Free Report ) by 6.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 12,711 shares of the company’s stock after selling 897 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Pediatrix Medical Group were worth $147,000 at the end of the most recent reporting period. Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in shares of Pediatrix Medical Group by 1.6% in the first quarter. Vanguard Group Inc. now owns 10,557,572 shares of the company’s stock worth $105,892,000 after acquiring an additional 164,333 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in Pediatrix Medical Group by 4.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 87,369 shares of the company’s stock worth $877,000 after purchasing an additional 3,669 shares during the period. Tidal Investments LLC purchased a new stake in Pediatrix Medical Group during the 1st quarter valued at approximately $442,000. Virtu Financial LLC bought a new stake in shares of Pediatrix Medical Group during the first quarter valued at approximately $124,000. Finally, Boston Partners lifted its holdings in shares of Pediatrix Medical Group by 34.0% in the first quarter. Boston Partners now owns 1,786,434 shares of the company’s stock worth $17,702,000 after buying an additional 453,254 shares in the last quarter. 97.71% of the stock is owned by hedge funds and other institutional investors. Insider Activity at Pediatrix Medical Group In other Pediatrix Medical Group news, EVP Mary Ann E. Moore sold 8,108 shares of the company’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $16.00, for a total value of $129,728.00. Following the completion of the sale, the executive vice president now directly owns 135,810 shares in the company, valued at approximately $2,172,960. This represents a 5.63 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink . Also, Director Mark S. Ordan sold 27,600 shares of the firm’s stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $15.35, for a total value of $423,660.00. Following the transaction, the director now owns 138,683 shares in the company, valued at approximately $2,128,784.05. This represents a 16.60 % decrease in their position. The disclosure for this sale can be found here . 2.00% of the stock is currently owned by company insiders. Wall Street Analysts Forecast Growth Read Our Latest Research Report on Pediatrix Medical Group Pediatrix Medical Group Stock Performance NYSE:MD opened at $14.96 on Friday. The firm has a market capitalization of $1.28 billion, a PE ratio of -4.89, a PEG ratio of 2.10 and a beta of 1.55. The stock’s fifty day moving average is $13.25 and its 200 day moving average is $10.21. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $16.41. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.42 and a current ratio of 1.42. Pediatrix Medical Group ( NYSE:MD – Get Free Report ) last issued its quarterly earnings results on Friday, November 1st. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.37 by $0.07. The company had revenue of $511.20 million for the quarter, compared to the consensus estimate of $498.87 million. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. The firm’s revenue was up .9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.29 EPS. On average, sell-side analysts anticipate that Pediatrix Medical Group, Inc. will post 1.26 earnings per share for the current year. Pediatrix Medical Group Profile ( Free Report ) Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. Further Reading Five stocks we like better than Pediatrix Medical Group How to Invest in Blue Chip Stocks The Latest 13F Filings Are In: See Where Big Money Is Flowing Using the MarketBeat Dividend Tax Calculator 3 Penny Stocks Ready to Break Out in 2025 Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter .

Kinkead Dent and diverse ground game powers UT Martin past New Hampshire, 41-10 in FCS 1st roundPutin claims Russia attacked Ukraine with a new missile that the West can't stopDave & Buster’s Entertainment ( NASDAQ:PLAY – Free Report ) had its price objective decreased by BMO Capital Markets from $55.00 to $51.00 in a research note issued to investors on Tuesday morning, Benzinga reports. BMO Capital Markets currently has an outperform rating on the restaurant operator’s stock. A number of other equities analysts also recently commented on the company. Loop Capital reduced their price objective on Dave & Buster’s Entertainment from $63.00 to $59.00 and set a “buy” rating on the stock in a research report on Thursday, September 12th. Benchmark initiated coverage on Dave & Buster’s Entertainment in a research report on Monday, October 7th. They set a “hold” rating on the stock. Truist Financial reduced their price objective on Dave & Buster’s Entertainment from $59.00 to $56.00 and set a “buy” rating on the stock in a research report on Tuesday. Finally, StockNews.com downgraded Dave & Buster’s Entertainment from a “hold” rating to a “sell” rating in a research report on Wednesday, September 11th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Dave & Buster’s Entertainment has an average rating of “Hold” and a consensus target price of $61.57. View Our Latest Report on Dave & Buster’s Entertainment Dave & Buster’s Entertainment Stock Performance Dave & Buster’s Entertainment ( NASDAQ:PLAY – Get Free Report ) last released its earnings results on Tuesday, September 10th. The restaurant operator reported $1.12 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.28. The business had revenue of $557.10 million for the quarter, compared to the consensus estimate of $560.65 million. Dave & Buster’s Entertainment had a return on equity of 51.75% and a net margin of 5.10%. The business’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.94 earnings per share. As a group, equities research analysts anticipate that Dave & Buster’s Entertainment will post 2.59 EPS for the current fiscal year. Insider Buying and Selling at Dave & Buster’s Entertainment In other news, CEO Christopher Daniel Morris acquired 14,912 shares of the company’s stock in a transaction dated Monday, October 7th. The stock was acquired at an average cost of $33.67 per share, with a total value of $502,087.04. Following the completion of the purchase, the chief executive officer now owns 83,847 shares of the company’s stock, valued at $2,823,128.49. This represents a 21.63 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this link . Company insiders own 1.60% of the company’s stock. Institutional Investors Weigh In On Dave & Buster’s Entertainment A number of institutional investors have recently modified their holdings of PLAY. Eminence Capital LP grew its stake in shares of Dave & Buster’s Entertainment by 69.3% in the second quarter. Eminence Capital LP now owns 3,768,476 shares of the restaurant operator’s stock valued at $150,023,000 after buying an additional 1,542,154 shares in the last quarter. Rubric Capital Management LP grew its stake in shares of Dave & Buster’s Entertainment by 104.7% in the second quarter. Rubric Capital Management LP now owns 1,225,000 shares of the restaurant operator’s stock valued at $48,767,000 after buying an additional 626,497 shares in the last quarter. Sea Cliff Partners Management LP grew its stake in shares of Dave & Buster’s Entertainment by 90.8% in the second quarter. Sea Cliff Partners Management LP now owns 515,043 shares of the restaurant operator’s stock valued at $20,504,000 after buying an additional 245,043 shares in the last quarter. Marshall Wace LLP grew its stake in shares of Dave & Buster’s Entertainment by 36.2% in the second quarter. Marshall Wace LLP now owns 640,096 shares of the restaurant operator’s stock valued at $25,482,000 after buying an additional 170,286 shares in the last quarter. Finally, Hennessy Advisors Inc. acquired a new stake in shares of Dave & Buster’s Entertainment in the second quarter valued at $5,191,000. 91.45% of the stock is owned by institutional investors and hedge funds. Dave & Buster’s Entertainment Company Profile ( Get Free Report ) Dave & Buster's Entertainment, Inc owns and operates entertainment and dining venues for adults and families. Its venues offer a menu of entrees and appetizers, as well as a selection of non-alcoholic and alcoholic beverages; and an assortment of entertainment attractions centered on playing games and watching live sports, and other televised events. Featured Stories Five stocks we like better than Dave & Buster’s Entertainment There Are Different Types of Stock To Invest In The Latest 13F Filings Are In: See Where Big Money Is Flowing Health Care Stocks Explained: Why You Might Want to Invest 3 Penny Stocks Ready to Break Out in 2025 2 Fintech Stocks to Buy Now and 1 to Avoid FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential Receive News & Ratings for Dave & Buster's Entertainment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dave & Buster's Entertainment and related companies with MarketBeat.com's FREE daily email newsletter .